Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_provenance.
- NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_assertion description "[The ERCC2 genotype appears as an important predictive factor of the survival of patients treated with oxaliplatin in first-line therapy for metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_provenance.
- NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_assertion evidence source_evidence_literature NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_provenance.
- NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_assertion SIO_000772 18085999 NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_provenance.
- NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_assertion wasDerivedFrom befree-20150227 NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_provenance.
- NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_assertion wasGeneratedBy ECO_0000203 NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP382170.RAcu-rivLxmAAr3WdtdHhn2LZM943JTfUoM9ZnqOxA5mA130_provenance.